e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Therapeutic approaches in inflammatory lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Antioxidant efficiency in the treatment of asthma exacerbations
Usman Farkhutdinov (Ufa, Republic of Bashkortostan, Russian Federation), Usman Farkhutdinov, Shamil Farkhutdinov
Source:
International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Session:
Therapeutic approaches in inflammatory lung disease
Session type:
Thematic Poster Session
Number:
3890
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Usman Farkhutdinov (Ufa, Republic of Bashkortostan, Russian Federation), Usman Farkhutdinov, Shamil Farkhutdinov. Antioxidant efficiency in the treatment of asthma exacerbations. Eur Respir J 2015; 46: Suppl. 59, 3890
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Serious asthma exacerbations in a hospital setting
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Use of β-blockers and the risk of asthma exacerbations
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016
Study of antioxidant use in patients with asthma exacerbations
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
Clinical effectiveness of anti-IgE therapy in allergic severe asthma
Source: International Congress 2014 – Asthma and COPD management
Year: 2014
Morphofunctional study of bronchial asthma with extrahospital pneumonia
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014
Outcomes of immunotherapy of patients with COPD
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Acute exacerbations of asthma in Barcelona, the recent experience
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013
P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients
Source: International Congress 2016 – Asthma management
Year: 2016
Evaluating omalizumab persistency of response after long-term therapy (XPORT)
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
The impact of bacterial lysate on asthma prevention in mouse and its mechanism
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
When needed use of inhaled steroids in children with asthma
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Applying the 3Rs to asthma research
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Experience with omalizumab in patients with moderate and severe asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma
Source: Annual Congress 2013 –Genetic factors in airway development and disease
Year: 2013
Predictors of exacerbations in asthma
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Combined therapy of asthma and allergic rhinitis
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Guideline adherence and cost of asthma treatment at emergency department
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Total and free IgE in evolution of severe asthma after omalizumab treatment
Source: International Congress 2016 – Asthma management
Year: 2016
Chronic dosing effects of propranolol in asthma
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept